KPRX icon

Kiora Pharmaceuticals
KPRX

Overview Fund Trends Analyst Outlook Journalist POV

11 hedge funds and large institutions have $519K invested in Kiora Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more ownership

Funds ownership: →

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

Holders
11
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$286K
2
+$113K
3
+$40.1K
4
TRCT
Tower Research Capital (TRC)
New York
+$15K
5
UBS Group
UBS Group
Switzerland
+$7.25K

Top Sellers

1
-$86K
2
-$7.67K
3
-$6K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$286K
2
$113K
3
$49.6K
4
$40.1K
5
$15K
6
$14.6K
7
$397
8
$230
9
$24
10
$21
11
–
12
–